Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Devika Patel

Showing results (41-50 of 47) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 47 results.
Plos Medicine|May 6, 2021
Digital adherence technology for tuberculosis treatment supervision: A stepped-wedge cluster-randomized trial in UgandaAdithya Cattamanchi, Rebecca Crowder, Alex Kityamuwesi, et al.
PLOS Digital Health|June 30, 2023
Implementation, feasibility, and acceptability of 99DOTS-based supervision of treatment for drug-susceptible TB in UgandaNoah Kiwanuka, Alex Kityamuwesi, Rebecca Crowder, et al.
Implementation Science : IS|August 14, 2020
Protocol for the 3HP Options Trial: a hybrid type 3 implementation-effectiveness randomized trial of delivery strategies for short-course tuberculosis preventive therapy among people living with HIV in UgandaJillian L Kadota, Allan Musinguzi, Juliet Nabunje, et al.
Plos Medicine|December 16, 2021
Completion of isoniazid-rifapentine (3HP) for tuberculosis prevention among people living with HIV: Interim analysis of a hybrid type 3 effectiveness-implementation randomized trialFred C Semitala, Jillian L Kadota, Allan Musinguzi, et al.
Plos Medicine|February 20, 2024
Comparison of 3 optimized delivery strategies for completion of isoniazid-rifapentine (3HP) for tuberculosis prevention among people living with HIV in Uganda: A single-center randomized trialFred C Semitala, Jillian L Kadota, Allan Musinguzi, et al.
Medrxiv : the Preprint Server for Health Sciences|September 24, 2024
Evaluating the implementation of weekly rifapentine-isoniazid (3HP) for tuberculosis prevention among people living with HIV in Uganda: A qualitative evaluation of the 3HP Options TrialAllan Musinguzi, Joan R Kasidi, Jillian L Kadota, et al.
PLOS Global Public Health|October 24, 2024
Evaluating the implementation of weekly rifapentine-isoniazid (3HP) for tuberculosis prevention among people living with HIV in Uganda: A qualitative evaluation of the 3HP Options TrialAllan Musinguzi, Joan R Kasidi, Jillian L Kadota, et al.
Pageof 5

Showing results (41-50 of 47) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 47 results.
Plos Medicine|May 6, 2021
Digital adherence technology for tuberculosis treatment supervision: A stepped-wedge cluster-randomized trial in UgandaAdithya Cattamanchi, Rebecca Crowder, Alex Kityamuwesi, et al.
PLOS Digital Health|June 30, 2023
Implementation, feasibility, and acceptability of 99DOTS-based supervision of treatment for drug-susceptible TB in UgandaNoah Kiwanuka, Alex Kityamuwesi, Rebecca Crowder, et al.
Implementation Science : IS|August 14, 2020
Protocol for the 3HP Options Trial: a hybrid type 3 implementation-effectiveness randomized trial of delivery strategies for short-course tuberculosis preventive therapy among people living with HIV in UgandaJillian L Kadota, Allan Musinguzi, Juliet Nabunje, et al.
Plos Medicine|December 16, 2021
Completion of isoniazid-rifapentine (3HP) for tuberculosis prevention among people living with HIV: Interim analysis of a hybrid type 3 effectiveness-implementation randomized trialFred C Semitala, Jillian L Kadota, Allan Musinguzi, et al.
Plos Medicine|February 20, 2024
Comparison of 3 optimized delivery strategies for completion of isoniazid-rifapentine (3HP) for tuberculosis prevention among people living with HIV in Uganda: A single-center randomized trialFred C Semitala, Jillian L Kadota, Allan Musinguzi, et al.
Medrxiv : the Preprint Server for Health Sciences|September 24, 2024
Evaluating the implementation of weekly rifapentine-isoniazid (3HP) for tuberculosis prevention among people living with HIV in Uganda: A qualitative evaluation of the 3HP Options TrialAllan Musinguzi, Joan R Kasidi, Jillian L Kadota, et al.
PLOS Global Public Health|October 24, 2024
Evaluating the implementation of weekly rifapentine-isoniazid (3HP) for tuberculosis prevention among people living with HIV in Uganda: A qualitative evaluation of the 3HP Options TrialAllan Musinguzi, Joan R Kasidi, Jillian L Kadota, et al.
Pageof 5